BackNeogen Overview
Neogen Corp.

Neogen Target Price

Where could NEOG trade next? Consensus target price: $13.

Get informed when a big investor buys or sells

+ Follow

Share Price

$11.83

Average Target Price

$13.009.9% upside

1 analysts in the last 4 months

High: $13 | Low: $13

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-08-03Piper Sandler$139.9% upsideOpen
2026-01-12Piper SandlerDavid Westenberg$1015.5% downsideOpen
2026-01-09Guggenheim$121.4% upsideOpen
2025-10-16Piper SandlerDavid Westenberg$6.545.1% downsideOpen
2025-04-22Piper SandlerDavid Westenberg$557.7% downsideOpen
2024-08-06Piper SandlerDavid Westenberg$17.547.9% upsideOpen
2022-12-14Piper SandlerDavid Westenberg$1743.7% upsideOpen
2022-10-09Piper SandlerDavid Westenberg$1418.3% upsideOpen

Neogen (NEOG) FAQ

Neogen (NEOG) currently reports a target price of $13. Use the charts on this page to explore Neogen's target price history and peer comparisons.

Analysts' average 12-month price target for Neogen is $13, about 9.9% upside from the current share price of $11.83. That spread summarizes where covering analysts expect the stock could trade over the next year, not a guarantee. Review the individual firm targets on this page — a wide high-to-low range often means opinion is split.

Start with the current target price of $13, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Neogen, and consider following NEOG for alerts when major investors trade the stock.

Neogen is classified in the Healthcare sector. On target price, it currently shows $13. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing NEOG with unrelated industries.